Gan To Kagaku Ryoho. 2009 Feb;36(2):321-3.

[A case of metastatic pancreatic cancer after combination chemotherapy with uracil-tegafur and gemcitabine].

[Article in Japanese]

Sugimoto K, Okada K, Nakahira S, Okamura S, Miki H, Nakata K, Suzuki R, Yoshimura M, Uji K, Yoshida A, Tamura S.

Source

Dept. of Gastroenterological Surgery, Kansai Rosai Hospital.

Abstract

We report a case of pancreas head cancer with liver metastasis treated with uracil-tegafur (UFT) and gemcitabine combined chemotherapy. A 66-year-old man was referred to our hospital for obstructive jaundice. We planned to perform a pancreatoduodenectomy, but a small nodule was found at laparotomy on the liver surface. The histopathological diagnosis was adenocarcinoma, so we inserted a self-expandable metallic stent (EMS) in this inoperable pancreas head cancer. We performed 9 courses of UFT and gemcitabine (GEM) combination chemotherapy. Renewed liver metastases did not appear, and the pancreas head tumor partially responded. Pancreatoduodenectomy was performed, and EMS could not be separated from the common bile duct. After treatment with an additional 11 courses of chemotherapy, he took S-1 orally because of a tumor recurrence. He survived for 24 months from the first laparotomy. Combination chemotherapy and surgery enhanced the survival benefit in this case.

PMID:: 19223756; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Sunmedia PierOnline

Medical

Pancreatic Cancer - MedlinePlus Health Information

Supplemental Content

Related citations

[A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy]. [Gan To Kagaku Ryoho. 2011]
[A case of complete response of gemcitabine (GEM) monotherapy-refractive liver metastatic pancreatic cancer treated with GEM+S-1 combined chemotherapy].
Hatata T, Takaya S, Taniguchi K, Naka T, Kondo A, Ikeguchi M. Gan To Kagaku Ryoho. 2011 Jan; 38(1):109-12.
[Effective combination chemotherapy with gemcitabine hydrochloride, S-1 and nedaplatin for recurrent pancreatic cancer--a case report]. [Gan To Kagaku Ryoho. 2008]
[Effective combination chemotherapy with gemcitabine hydrochloride, S-1 and nedaplatin for recurrent pancreatic cancer--a case report].
Tokairin Y, Iida M, Yamazaki S. Gan To Kagaku Ryoho. 2008 Nov; 35(12):2123-5.
[A patient with pancreatic cancer and multiple liver metastases after total pancreatectomy who showed a partial response to combination chemotherapy with gemcitabine and UFT]. [Gan To Kagaku Ryoho. 2006]
[A patient with pancreatic cancer and multiple liver metastases after total pancreatectomy who showed a partial response to combination chemotherapy with gemcitabine and UFT].
Machida H, Ushida S, Suzuki K, Toda H. Gan To Kagaku Ryoho. 2006 Sep; 33(9):1333-5.
Review Metastatic pancreatic cancer response to treatment with cetuximab and gemcitabine plus capecitabine: a case report and review of the literature. [Tumori. 2010]
Review Metastatic pancreatic cancer response to treatment with cetuximab and gemcitabine plus capecitabine: a case report and review of the literature.
Li M, Jiang M, Yan X, Wang F, Luo F. Tumori. 2010 Sep-Oct; 96(5):764-7.
Review Pancreatic carcinosarcoma. Case report of multimodal therapy and review of the literature. [JOP. 2008]
Review Pancreatic carcinosarcoma. Case report of multimodal therapy and review of the literature.
Gelos M, Behringer D, Philippou S, Mann B. JOP. 2008 Jan 8; 9(1):50-5. Epub 2008 Jan 8.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

[A case of metastatic pancreatic cancer after combination chemotherapy with urac...
[A case of metastatic pancreatic cancer after combination chemotherapy with uracil-tegafur and gemcitabine].
Gan To Kagaku Ryoho. 2009 Feb ;36(2):321-3.

PubMed
Mutation of an A-kinase-anchoring protein causes long-QT syndrome.
Mutation of an A-kinase-anchoring protein causes long-QT syndrome.
Proc Natl Acad Sci U S A. 2007 Dec 26 ;104(52):20990-5. Epub 2007 Dec 19 .

PubMed
Mobilisation with movement and exercise, corticosteroid injection, or wait and s...
Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial.
BMJ. 2006 Nov 4 ;333(7575):939. Epub 2006 Sep 29 .

PubMed
Structure-based design of Aurora A & B inhibitors.
Structure-based design of Aurora A & B inhibitors.
J Comput Aided Mol Des. 2008 Dec ;22(12):897-906. Epub 2008 Jun 24 .

PubMed
The effect of adjuvant and neoadjuvant chemo(radio)therapy on survival in 1,679 ...
The effect of adjuvant and neoadjuvant chemo(radio)therapy on survival in 1,679 resected pancreatic carcinoma cases in Japan: report of the national survey in the 34th annual meeting of Japanese Society of Pancreatic Surgery.
J Hepatobiliary Pancreat Surg. 2009 ;16(4):485-92. Epub 2009 Mar 31 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

[A case of metastatic pancreatic cancer after combination chemotherapy with uracil-tegafur and gemcitabine].

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Related citations

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information